These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28460571)

  • 1. MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
    Gautam SK; Kumar S; Cannon A; Hall B; Bhatia R; Nasser MW; Mahapatra S; Batra SK; Jain M
    Expert Opin Ther Targets; 2017 Jul; 21(7):657-669. PubMed ID: 28460571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.
    Torres MP; Ponnusamy MP; Chakraborty S; Smith LM; Das S; Arafat HA; Batra SK
    Mol Cancer Ther; 2010 May; 9(5):1419-31. PubMed ID: 20423995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
    Momi N; Ponnusamy MP; Kaur S; Rachagani S; Kunigal SS; Chellappan S; Ouellette MM; Batra SK
    Oncogene; 2013 Mar; 32(11):1384-95. PubMed ID: 22614008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.
    Skrypek N; Duchêne B; Hebbar M; Leteurtre E; van Seuningen I; Jonckheere N
    Oncogene; 2013 Mar; 32(13):1714-23. PubMed ID: 22580602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
    Lahdaoui F; Delpu Y; Vincent A; Renaud F; Messager M; Duchêne B; Leteurtre E; Mariette C; Torrisani J; Jonckheere N; Van Seuningen I
    Oncogene; 2015 Feb; 34(6):780-8. PubMed ID: 24608432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
    Gautam SK; Kumar S; Dam V; Ghersi D; Jain M; Batra SK
    Semin Immunol; 2020 Feb; 47():101391. PubMed ID: 31952903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.
    Pai P; Rachagani S; Lakshmanan I; Macha MA; Sheinin Y; Smith LM; Ponnusamy MP; Batra SK
    Mol Oncol; 2016 Feb; 10(2):224-39. PubMed ID: 26526617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.
    Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS
    Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.
    Sagar S; Leiphrakpam PD; Thomas D; McAndrews KL; Caffrey TC; Swanson BJ; Clausen H; Wandall HH; Hollingsworth MA; Radhakrishnan P
    Cancer Lett; 2021 Apr; 503():91-102. PubMed ID: 33485947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
    Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
    Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4.
    Gál E; Veréb Z; Kemény L; Rakk D; Szekeres A; Becskeházi E; Tiszlavicz L; Takács T; Czakó L; Hegyi P; Venglovecz V
    Sci Rep; 2020 Dec; 10(1):22088. PubMed ID: 33328627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
    Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
    Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.
    Mimeault M; Johansson SL; Senapati S; Momi N; Chakraborty S; Batra SK
    Cancer Lett; 2010 Sep; 295(1):69-84. PubMed ID: 20303649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine.
    Urey C; Andersson B; Ansari D; Sasor A; Said-Hilmersson K; Nilsson J; Andersson R
    Scand J Gastroenterol; 2017 May; 52(5):595-600. PubMed ID: 28270046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
    Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
    Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma.
    Zhu Y; Zhang JJ; Zhu R; Zhu Y; Liang WB; Gao WT; Yu JB; Xu ZK; Miao Y
    Med Oncol; 2011 Dec; 28 Suppl 1():S175-84. PubMed ID: 20922503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
    Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and
    Urey C; Hilmersson KS; Andersson B; Ansari D; Andersson R
    Anticancer Res; 2017 Nov; 37(11):6031-6039. PubMed ID: 29061782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.